{"entity":{"type":"insider","cik":"0001830363","url":"/insider/0001830363","json_url":"/insider/0001830363.json","name":"Renger John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":17,"first":"2021-11-15","last":"2024-02-08","span_basis":"filed_date"},"name_variants":[{"name":"Renger John","source":"filing","n_filings":17,"first_seen":"2021-11-15","last_seen":"2024-02-08"}],"transactions":[{"id":2203357,"accession":"0000950170-24-012962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-012962","line_url":"/filing/0000950170-24-012962#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2161.0,"shares_display":"2,161","price_per_share":41.5441,"price_display":"41.54","price_state":"stated","total_value":89776.8001,"total_display":"89,776.80","shares_owned_after":6370.0,"shares_owned_after_display":"6,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":6414888,"accession":"0000899243-22-034915","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-034915","line_url":"/filing/0000899243-22-034915#line-3","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0002,"price_display":"30.00","price_state":"stated","total_value":750005.0,"total_display":"750,005.00","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6841615,"accession":"0000899243-22-033167","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033167","line_url":"/filing/0000899243-22-033167#line-3","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"},{"id":6291239,"accession":"0000899243-22-028481","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-028481","line_url":"/filing/0000899243-22-028481#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36141.0,"shares_display":"36,141","price_per_share":40.1907,"price_display":"40.19","price_state":"stated","total_value":1452532.0887,"total_display":"1,452,532.09","shares_owned_after":21563.0,"shares_owned_after_display":"21,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"},{"id":6291236,"accession":"0000899243-22-028481","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-028481","line_url":"/filing/0000899243-22-028481#line-3","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18859.0,"shares_display":"18,859","price_per_share":41.0993,"price_display":"41.10","price_state":"stated","total_value":775091.6987,"total_display":"775,091.70","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"},{"id":6691496,"accession":"0000899243-22-028190","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-028190","line_url":"/filing/0000899243-22-028190#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.75,"price_display":"37.75","price_state":"stated","total_value":377500.0,"total_display":"377,500.00","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":6691492,"accession":"0000899243-22-028190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-028190","line_url":"/filing/0000899243-22-028190#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":650000.0,"total_display":"650,000.00","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"},{"id":6588645,"accession":"0000899243-22-026577","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-026577","line_url":"/filing/0000899243-22-026577#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider"},{"id":6741533,"accession":"0000899243-22-025685","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-025685","line_url":"/filing/0000899243-22-025685#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1105.0,"shares_display":"1,105","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":35912.5,"total_display":"35,912.50","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-07","scope":"insider"},{"id":6741530,"accession":"0000899243-22-025685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-025685","line_url":"/filing/0000899243-22-025685#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","shares_owned_after":2704.0,"shares_owned_after_display":"2,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-07","scope":"insider"},{"id":6914108,"accession":"0000899243-22-014882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-014882","line_url":"/filing/0000899243-22-014882#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":34.6465,"price_display":"34.65","price_state":"stated","total_value":1559092.5,"total_display":"1,559,092.50","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-13","filed_date":"2022-04-15","scope":"insider"},{"id":6588128,"accession":"0000899243-22-012940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-012940","line_url":"/filing/0000899243-22-012940#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":6973771,"accession":"0000899243-22-011639","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-011639","line_url":"/filing/0000899243-22-011639#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":32.5002,"price_display":"32.50","price_state":"stated","total_value":650004.0,"total_display":"650,004.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-18","scope":"insider"},{"id":6973766,"accession":"0000899243-22-011639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011639","line_url":"/filing/0000899243-22-011639#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0002,"price_display":"30.00","price_state":"stated","total_value":750005.0,"total_display":"750,005.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":6502275,"accession":"0000899243-22-010697","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-010697","line_url":"/filing/0000899243-22-010697#line-3","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":650000.0,"total_display":"650,000.00","shares_owned_after":11980.0,"shares_owned_after_display":"11,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-11","scope":"insider"},{"id":6502272,"accession":"0000899243-22-010697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-010697","line_url":"/filing/0000899243-22-010697#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-11","scope":"insider"},{"id":6767293,"accession":"0000899243-22-009392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-009392","line_url":"/filing/0000899243-22-009392#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":6740448,"accession":"0000899243-22-005941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-005941","line_url":"/filing/0000899243-22-005941#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":5195115,"accession":"0000899243-21-049933","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-049933","line_url":"/filing/0000899243-21-049933#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4127.0,"shares_display":"4,127","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":144445.0,"total_display":"144,445.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-28","scope":"insider"},{"id":5195109,"accession":"0000899243-21-049933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-049933","line_url":"/filing/0000899243-21-049933#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5873.0,"shares_display":"5,873","price_per_share":35.0046,"price_display":"35.00","price_state":"stated","total_value":205582.0158,"total_display":"205,582.02","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-28","scope":"insider"},{"id":5492170,"accession":"0000899243-21-049620","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-049620","line_url":"/filing/0000899243-21-049620#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":237250.0,"total_display":"237,250.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-23","scope":"insider"},{"id":5039449,"accession":"0000899243-21-048894","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-048894","line_url":"/filing/0000899243-21-048894#line-6","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7122.0,"shares_display":"7,122","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":231465.0,"total_display":"231,465.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-17","scope":"insider"},{"id":5039438,"accession":"0000899243-21-048894","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-048894","line_url":"/filing/0000899243-21-048894#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5578.0,"shares_display":"5,578","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":181285.0,"total_display":"181,285.00","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-17","scope":"insider"},{"id":5039431,"accession":"0000899243-21-048894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-048894","line_url":"/filing/0000899243-21-048894#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0179,"price_display":"30.02","price_state":"stated","total_value":750447.5,"total_display":"750,447.50","shares_owned_after":1980.0,"shares_owned_after_display":"1,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":5088028,"accession":"0000899243-21-044579","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-044579","line_url":"/filing/0000899243-21-044579#line-6","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23632.0,"shares_display":"23,632","price_per_share":38.5894,"price_display":"38.59","price_state":"stated","total_value":911944.7008,"total_display":"911,944.70","shares_owned_after":31368.0,"shares_owned_after_display":"31,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-15","scope":"insider"},{"id":5088027,"accession":"0000899243-21-044579","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-044579","line_url":"/filing/0000899243-21-044579#line-5","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13140.0,"shares_display":"13,140","price_per_share":41.4372,"price_display":"41.44","price_state":"stated","total_value":544484.808,"total_display":"544,484.81","shares_owned_after":2063.0,"shares_owned_after_display":"2,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-15","scope":"insider"},{"id":5088026,"accession":"0000899243-21-044579","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-044579","line_url":"/filing/0000899243-21-044579#line-4","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10030.0,"shares_display":"10,030","price_per_share":40.4123,"price_display":"40.41","price_state":"stated","total_value":405335.369,"total_display":"405,335.37","shares_owned_after":15203.0,"shares_owned_after_display":"15,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-15","scope":"insider"},{"id":5088025,"accession":"0000899243-21-044579","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-044579","line_url":"/filing/0000899243-21-044579#line-3","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6135.0,"shares_display":"6,135","price_per_share":39.6094,"price_display":"39.61","price_state":"stated","total_value":243003.669,"total_display":"243,003.67","shares_owned_after":25233.0,"shares_owned_after_display":"25,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-15","scope":"insider"},{"id":5088024,"accession":"0000899243-21-044579","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-044579","line_url":"/filing/0000899243-21-044579#line-2","is_derivative":false,"issuer_cik":"0001805387","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001805387","owner_cik":"0001830363","owner_name":"Renger John","owner_url":"/insider/0001830363","role":"Officer (Chief Scientific Officer)","officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2063.0,"shares_display":"2,063","price_per_share":42.3746,"price_display":"42.37","price_state":"stated","total_value":87418.7998,"total_display":"87,418.80","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001805387","name":"Cerevel Therapeutics Holdings, Inc.","url":"/issuer/0001805387","role":"Officer (Chief Scientific Officer)","n_filings":17,"first_seen":"2021-11-15","last_seen":"2024-02-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001830363","retrieved_at":"2026-08-21T20:09:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}